408 related articles for article (PubMed ID: 25297562)
1. The use of CA-IX as a diagnostic method for oral leukoplakia.
Pérez-Sayáns M; Suárez-Peñaranda JM; Torres-López M; Supuran CT; Gándara-Vila P; Gayoso-Diz P; Barros-Angueira F; Gallas-Torreira M; García-García A
Biotech Histochem; 2015 Feb; 90(2):124-31. PubMed ID: 25297562
[TBL] [Abstract][Full Text] [Related]
2. Expression of CA IX in dysplasia adjacent to surgical resection margins of oral squamous cell carcinoma.
Pérez-Sayáns M; Suárez-Peñaranda JM; Torres-López M; Supuran CT; Gándara-Vila P; Gayoso-Diz P; Barros-Angueira F; Blanco-Carrión A; Gándara-Rey JM; García-García A
Biotech Histochem; 2014 Feb; 89(2):91-7. PubMed ID: 23957700
[TBL] [Abstract][Full Text] [Related]
3. [Leukoplakia and erythroplakia--two orale precursor lesions].
Grajewski S; Groneberg D
Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
[TBL] [Abstract][Full Text] [Related]
4. Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients.
Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Supuran CT; Pastorekova S; Barros-Angueira F; Gándara-Rey JM; García-García A
J Oral Pathol Med; 2012 Oct; 41(9):667-74. PubMed ID: 22486898
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
D'souza B; Nayak R; Kotrashetti VS
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
[TBL] [Abstract][Full Text] [Related]
8. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
9. Computer aided morphometric analysis of oral leukoplakia and oral squamous cell carcinoma.
Gupta K; Gupta J; Miglani R
Biotech Histochem; 2016; 91(4):251-4. PubMed ID: 26983454
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
Kim SJ; Shin HJ; Jung KY; Baek SK; Shin BK; Choi J; Kim BS; Shin SW; Kim YH; Kim JS; Oosterwijk E
Jpn J Clin Oncol; 2007 Nov; 37(11):812-9. PubMed ID: 18057013
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX: a promising diagnostic and prognostic biomarker in breast carcinoma.
Furjelová M; Kovalská M; Jurková K; Horáček J; Carbolová T; Adamkov M
Acta Histochem; 2014 Jan; 116(1):89-93. PubMed ID: 23816158
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
[TBL] [Abstract][Full Text] [Related]
15. Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody.
Chrastina A; Pastoreková S; Pastorek J
Neoplasma; 2003; 50(1):13-21. PubMed ID: 12687273
[TBL] [Abstract][Full Text] [Related]
16. [Study of testicular cancer gene expression in samples of oral leukoplakia and squamous cell carcinoma of the mouth].
Skorodumova LO; Muraev AA; Zakharova ES; Shepelev MV; Korobko IV; Zaderenko IA; Ivanov SIu; Gnuchev NV; Georgiev GP; Larin SS
Vopr Onkol; 2012; 58(4):486-92. PubMed ID: 23607202
[TBL] [Abstract][Full Text] [Related]
17. [A scientometric analysis of leukoplakia and erythroplakia].
Grajewski S; Quarcoo D; Uibel S; Scutaru C; Groneberg D; Spallek M
Laryngorhinootologie; 2010 Apr; 89(4):210-5. PubMed ID: 20387174
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma.
Vermylen P; Roufosse C; Burny A; Verhest A; Bosschaerts T; Pastorekova S; Ninane V; Sculier JP
Eur Respir J; 1999 Oct; 14(4):806-11. PubMed ID: 10573225
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
20. [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression].
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Ned Tijdschr Tandheelkd; 2021 Feb; 128(2):103-111. PubMed ID: 33605260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]